Regulatory Copilot

assyro.com
Visit site

Accelerate drug submissions with Assyro, the AI regulatory copilot. Draft faster, validate in half the time, and submit without rework.

Description

Assyro is an AI Regulatory Copilot designed for the pharmaceutical and biotech industries, aiming to accelerate drug submissions and reduce rework. It offers clause-level intelligence that helps in drafting regulatory documents 3x faster and validates them in half the time, ensuring audit-ready trails for drugs and biologics. By leveraging AI, Assyro minimizes risks, streamlines the regulatory process, and offers real-time eCTD validation, positioning itself as an essential tool for companies navigating complex regulations, and improving user experience with features that simplify compliance and enhance accuracy.

Installation

Not sure where to start — ask an assistant to walk you through:

Features

🚀 Clause-Level Intelligence
AI analyzes regulatory clauses for accuracy and compliance, reducing drafting time and errors significantly. This allows users to navigate complex documents efficiently, ensuring all submissions meet regulatory standards
🔬 Real-Time eCTD Validation
Automatically validates electronic Common Technical Document (eCTD) submissions, ensuring they meet all necessary formatting and content requirements in real-time. This feature minimizes the risk of rejection, saving tim
✅ Audit-Ready Trails
Maintains comprehensive, audit-ready trails of all changes and validations, providing transparency and accountability. This helps in preparing for audits and reduces the effort involved in demonstrating compliance. Maint

Use cases

Drafting IND submissions rapidly, reducing overall time.
Validating eCTD formats quickly, avoiding potential submission delays.
Maintaining audit logs securely for regulatory compliance.
Analyzing regulatory clauses, ensuring accurate document creation
Reducing submission rework, cutting compliance costs.

FAQ

Assyro is an AI Regulatory Copilot designed for the pharmaceutical and biotech industries to accelerate drug submissions and ensure compliance.

Assyro accelerates submissions by providing clause-level intelligence, real-time eCTD validation, and audit-ready trails, enabling faster drafting and validation.

Clause-level intelligence refers to Assyro's AI-driven analysis of regulatory clauses, ensuring accuracy and compliance in documentation.

Assyro validates electronic Common Technical Documents (eCTD) in real-time to ensure they meet all necessary formatting and content requirements.

Audit-ready trails are comprehensive records of all changes and validations maintained by Assyro, providing transparency and accountability for audits.

Assyro can be beneficial, but cost may be a consideration for smaller companies; assess ROI based on submission volume.

Assyro supports CFR Title 21, USC Title 21, and US Letters, among other regulatory content.

By providing real-time validation and intelligent insights, Assyro helps avoid errors and ensures submissions are correct the first time.

Yes, Assyro is designed to support regulatory submissions for both drugs and biologics.

Early access can be requested via the 'Request Access' button on the Assyro website.

Specs

Type Tool
SectionAI Assistant
Pricing has a free tier
Platform Web only
Systems web
Hostingcloud
Installsaas
Site languageen
Vendorxingliang1 z
Launched2026-02-22

Found in sources

auraplusplus showmebest

Submit a site to the catalog

Just send the link — we will work out the rest.

We will review what you send and add it to the catalog if it fits.

Not sure how to implement it? We can help

Tell us about your task — we will pick the tools and suggest where to start.

0 / 5000
Verification code

Fields marked with an asterisk are required. Your data is used only to reply.